Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled Clinical Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 422 participants.

Also called NCT07314775

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 422 participants (planned count) (from the registry)
Sponsor
Xinjiang Uygur Pharmaceutical Co., Ltd. (from the registry)
Registry
  • NCT NCT07314775
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07314775. Randomized; double masking; primary purpose treatment. Start 2026-01 (anticipated); primary completion 2028-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled Clinical Study
Condition
Dyslipidemia
Condition
Carotid Atherosclerotic Plaques
Intervention (Drug)
Yangxin Dawayimixike Honey Paste
Intervention (Drug)
Yangxin Dawayimixike Honey Paste placebo
Lead sponsor
Xinjiang Uygur Pharmaceutical Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct07314775
Content hash
ac7a1b3ce98a0ee91eccfb69ef05e71ddb64de66ccc739329f50c70bb66a44d7